Serplulimab Combined With CAPEOX + Celecoxib as Neoadjuvant Treatment for Locally Advanced Rectal Cancer

NCT05731726 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

pMMR
MSS
MSI-L
Locally Advanced Rectal Carcinoma

Interventions

DRUG: Serplulimab
DRUG: Capecitabine
DRUG: Oxaliplatin
DRUG: Celecoxib

Sponsor

Zhejiang University